Antimnemonic therapy for hypermemory syndromes
CA 2465869 A1 · Owner: Haracz, John L. · Inventors: Haracz, John L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to antimnemonic therapy for the treatment of behaviroal disorders such as addiction obsessive-compulsive disorder, Tourette's Syndrome post-traumatic stress disorder (PTSD), bipolar disorder depression, schizophrenia, anxiety disorders and personality disorders. Antimnemonic therapy may involve cue- or psychotherapy-induced reactivation of memories in combination with the administration of antimnemonic drugs.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 5, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 5, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 5, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.